Home › Asset managers › Blackstone Alternative Investment Funds › 2025-2026 › Against the board
Two kinds of vote are listed: a board-sponsored proposal Blackstone Alternative Investment Funds voted AGAINST or withheld on, and a shareholder proposal it voted FOR, with the board’s recommendation on it where the filings show one. A FOR vote on a proposal the board supported, or took no position on, is listed and labelled, but it is not a vote against the board. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.
Everything Only shareholder proposals it backed
1,316 proposals.
| Company | Meeting | Proposal | Category | On the ballot from | Board recommended | Blackstone Alternative Investment Funds voted | Funds |
|---|---|---|---|---|---|---|---|
| MagnaChip Semiconductor Corporation | June 11, 2026 | Approval of the Company's Amended and Restated 2020 Equity and Incentive Compensation Plan. | Compensation | Board | AGAINST | 1 | |
| Maravai Lifesciences Holdings, Inc. | May 26, 2026 | To elect three nominees to the Board of Directors (3-year term expiring in 2029): Bernd Brust | Director Elections | Board | WITHHOLD | 1 | |
| Maravai Lifesciences Holdings, Inc. | May 26, 2026 | To elect three nominees to the Board of Directors (3-year term expiring in 2029): Gregory T. Lucier | Director Elections | Board | WITHHOLD | 1 | |
| Maravai Lifesciences Holdings, Inc. | May 26, 2026 | To elect three nominees to the Board of Directors (3-year term expiring in 2029): Luke Marker | Director Elections | Board | WITHHOLD | 1 | |
| Marex Group Plc | May 21, 2026 | Approve Scheme of Arrangement | Extraordinary Transactions | Board | AGAINST | 1 | |
| Marex Group plc | May 21, 2026 | Approve Capital Reduction by Cancellation and Extinguishment of the Deferred Shares | Capital Structure | Board | AGAINST | 1 | |
| Marex Group plc | May 21, 2026 | Approve Capital Reduction by Cancellation and Extinguishment of the Scheme Shares | Capital Structure | Board | AGAINST | 1 | |
| Marex Group plc | May 21, 2026 | Approve Scheme of Arrangement | Extraordinary Transactions | Board | AGAINST | 1 | |
| Marqeta, Inc. | June 10, 2026 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 1 | |
| Materialise NV | November 14, 2025 | Approve Remuneration Policy | Compensation | Board | AGAINST | 1 | |
| Materialise NV | June 16, 2026 | Approve Remuneration Report | Compensation | Board | AGAINST | 1 | |
| Materialise NV | June 16, 2026 | Reelect A TRE C BV, Permanently Represented by Johan De Lille, as Director | Director Elections | Board | AGAINST | 1 | |
| Materialise NV | June 16, 2026 | Reelect Jurgen Ingels as Director | Director Elections | Board | AGAINST | 1 | |
| MaxLinear, Inc. | May 20, 2026 | To approve an amendment and restatement of the MaxLinear, Inc. Amended and Restated 2010 Equity Incentive Plan, including approval of a new ten-year term and an increase in the number of shares reserved thereunder by 3,204,107. | Compensation | Board | AGAINST | 1 | |
| MaxLinear, Inc. | May 20, 2026 | To approve, on an advisory basis, the compensation of our named executive officers for the year ended December 31, 2025, as set forth in the proxy statement. | Say-on-Pay | Board | AGAINST | 1 | |
| MediciNova, Inc. | June 23, 2026 | To approve an amendment to the Company's Restated Certificate of Incorporation to increase the number of shares of common stock that the Company is authorized to issue from 100,000,000 to 247,000,000. | Capital Structure | Board | AGAINST | 1 | |
| Mereo BioPharma Group Plc | May 14, 2026 | That Justin Roberts be re-appointed as a director of the Company. | Director Elections | Board | AGAINST | 1 | |
| Mereo BioPharma Group Plc | May 14, 2026 | That the Directors be generally and unconditionally authorized in accordance with section 551 of the Companies Act 2006 (the "Act") to exercise all the powers of the Company to allot shares in the Company or to grant rights to subscribe for, or to convert securities into, shares in the Company up to a maximum aggregate nominal amount of £3,591,354.73, such authority to expire on June 30, 2029, save that the Company may, before such expiry, make offers or agreements which would, or might, require shares to be allotted or rights to subscribe for or to convert any securities into shares to be granted after such expiry and the Directors may allot shares or grant such rights under any such offer or agreement as if the authority conferred by this Resolution had not expired. Such authority shall replace the authority granted pursuant to section 551 of the Act at the annual general meeting of the Company held on May 22, 2023 to the extent not utilized at the date this Resolution is passed | Capital Structure | Board | AGAINST | 1 | |
| Mereo BioPharma Group Plc | May 14, 2026 | That, subject to Resolution 10 being passed, the Directors be generally empowered pursuant to section 570 and section 573 of the Act to allot equity securities for cash pursuant to the authority given by Resolution 10 and to sell equity securities held as treasury shares for cash pursuant to section 727 of the Act, in each case as if section 561(1) of the Act did not apply to any such allotment or sale, provided that this power shall be limited to the allotment or sale of equity securities up to an aggregate nominal value of £3,591,354.73, such power to expire on June 30, 2029, save that the Company may, before such expiry, make offers or agreements which would or might require equity securities to be allotted and equity securities held as treasury shares to be sold after such expiry, and the Directors may allot equity securities and sell equity securities held as treasury shares in pursuance of any such offer or agreement as if the power conferred hereby had not expired. Such power shall replace the power granted pursuant to section 570 and section 573 of the Act at the annual general meeting of the Company held on May 22, 2023 to the extent not utilized at the date this Resolution is passed. | Capital Structure | Board | AGAINST | 1 | |
| Meta Platforms, Inc. | May 27, 2026 | Election of Directors: Andrew W. Houston | Director Elections | Board | WITHHOLD | 1 | |
| Meta Platforms, Inc. | May 27, 2026 | Election of Directors: John Elkann | Director Elections | Board | WITHHOLD | 1 | |
| Meta Platforms, Inc. | May 27, 2026 | Election of Directors: Mark Zuckerberg | Director Elections | Board | WITHHOLD | 1 | |
| Meta Platforms, Inc. | May 27, 2026 | Election of Directors: Peggy Alford | Director Elections | Board | WITHHOLD | 1 | |
| Meta Platforms, Inc. | May 27, 2026 | Election of Directors: Tony Xu | Director Elections | Board | WITHHOLD | 1 | |
| Metagenomi Therapeutics, Inc. | June 9, 2026 | The director nominees this year are Class II directors: Juergen Eckhardt, MD, MBA | Director Elections | Board | WITHHOLD | 1 | |
| MetroCity Bankshares, Inc. | May 21, 2026 | Election of Directors: Francis Lai | Director Elections | Board | AGAINST | 1 | |
| Metropolitan Bank Holding Corp. | April 29, 2026 | Election of Directors: Maria Fiorini Ramirez - for a 3-year term | Director Elections | Board | WITHHOLD | 1 | |
| Miami International Holdings, Inc. | June 16, 2026 | The approval, on a non-binding advisory basis, of the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 1 | |
| Miami International Holdings, Inc. | June 16, 2026 | The election of the 15 director nominees: Talal Jassim Al-Bahar | Director Elections | Board | WITHHOLD | 1 | |
| Microsoft Corporation | December 5, 2025 | Report on Data Operations in Human Rights Hotspots | Human Rights or Human Capital/workforce | Shareholder | Against | FOR | 1 |
| Microsoft Corporation | December 5, 2025 | Report on Human Rights Due Diligence | Human Rights or Human Capital/workforce | Shareholder | Against | FOR | 1 |
| MidWestOne Financial Group, Inc. | January 26, 2026 | To approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to the named executive officers of MidWestOne that is based on or otherwise relates to the merger. | Say-on-Pay | Board | AGAINST | 1 | |
| Millrose Properties, Inc. | May 18, 2026 | Election of Directors: Carlos A. Migoya (Chair) | Director Elections | Board | AGAINST | 1 | |
| Millrose Properties, Inc. | May 18, 2026 | Election of Directors: M. Alison Mincey | Director Elections | Board | AGAINST | 1 | |
| Millrose Properties, Inc. | May 18, 2026 | Election of Directors: Matthew B. Gorson | Director Elections | Board | AGAINST | 1 | |
| Mirum Pharmaceuticals, Inc. | June 15, 2026 | To elect the Board's three Class I nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Lon Cardon, Ph.D., FMedSci | Director Elections | Board | WITHHOLD | 1 | |
| Mirum Pharmaceuticals, Inc. | June 15, 2026 | To elect the Board's three Class III nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Timothy Walbert | Director Elections | Board | WITHHOLD | 1 | |
| Mobileye Global Inc. | June 18, 2026 | Advisory vote on executive compensation. | Say-on-Pay | Board | AGAINST | 1 | |
| Mobileye Global Inc. | June 18, 2026 | Election of Directors: Amnon Shashua | Director Elections | Board | WITHHOLD | 1 | |
| Mobileye Global Inc. | June 18, 2026 | Election of Directors: Claire C. McCaskill | Director Elections | Board | WITHHOLD | 1 | |
| Mobileye Global Inc. | June 18, 2026 | Election of Directors: David Zinsner | Director Elections | Board | WITHHOLD | 1 | |
| Mobileye Global Inc. | June 18, 2026 | Election of Directors: Eyal Desheh | Director Elections | Board | WITHHOLD | 1 | |
| Mobileye Global Inc. | June 18, 2026 | Election of Directors: Nagasubramaniyan Chandrasekaran | Director Elections | Board | WITHHOLD | 1 | |
| Mobileye Global Inc. | June 18, 2026 | Election of Directors: Patrick Bombach | Director Elections | Board | WITHHOLD | 1 | |
| Mobileye Global Inc. | June 18, 2026 | Election of Directors: Safroadu Yeboah-Amankwah | Director Elections | Board | WITHHOLD | 1 | |
| Moderna, Inc. | May 6, 2026 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 1 | |
| Molina Healthcare, Inc. | May 6, 2026 | To consider and approve an amendment to the Company's 2025 Equity Incentive Plan to increase the number of shares available for issuance under such plan. | Compensation | Board | AGAINST | 1 | |
| Molina Healthcare, Inc. | May 6, 2026 | To consider and approve, on a non-binding, advisory basis, the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 1 | |
| MongoDB, Inc. | June 30, 2026 | Election of three Class III directors, each to serve until our Annual Meeting of Stockholders in 2029: Archana Agrawal | Director Elections | Board | WITHHOLD | 1 | |
| N-able, Inc. | May 28, 2026 | Election of Class II Directors: James Cameron McMartin | Director Elections | Board | WITHHOLD | 1 | |
| N-able, Inc. | May 28, 2026 | Election of Class II Directors: Michael Bingle | Director Elections | Board | WITHHOLD | 1 | |
| NACCO Industries, Inc. | May 15, 2026 | Election of Directors: Alfred M. Rankin, Jr. | Director Elections | Board | WITHHOLD | 1 | |
| NACCO Industries, Inc. | May 15, 2026 | Election of Directors: Britton T. Taplin | Director Elections | Board | WITHHOLD | 1 | |
| NACCO Industries, Inc. | May 15, 2026 | Election of Directors: Dennis W. LaBarre | Director Elections | Board | WITHHOLD | 1 | |
| NACCO Industries, Inc. | May 15, 2026 | Election of Directors: J.C. Butler, Jr. | Director Elections | Board | WITHHOLD | 1 | |
| NACCO Industries, Inc. | May 15, 2026 | Election of Directors: John P. Jumper | Director Elections | Board | WITHHOLD | 1 | |
| NACCO Industries, Inc. | May 15, 2026 | Election of Directors: John S. Dalrymple, III | Director Elections | Board | WITHHOLD | 1 | |
| NACCO Industries, Inc. | May 15, 2026 | Election of Directors: Matthew M. Rankin | Director Elections | Board | WITHHOLD | 1 | |
| NACCO Industries, Inc. | May 15, 2026 | Election of Directors: Michael S. Miller | Director Elections | Board | WITHHOLD | 1 | |
| NACCO Industries, Inc. | May 15, 2026 | Election of Directors: Valerie Gentile Sachs | Director Elections | Board | WITHHOLD | 1 | |
| NET Power Inc. | June 3, 2026 | Election of Class III Directors: Joseph Kelliher | Director Elections | Board | WITHHOLD | 1 | |
| NIKE, Inc. | September 9, 2025 | Class B director nominees: To elect a Board of Directors for the ensuing year: John Rogers, Jr. | Director Elections | Board | WITHHOLD | 1 | |
| NRC Health | June 23, 2026 | NON-BINDING, ADVISORY VOTE ON THE APPROVAL OF THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT. | Say-on-Pay | Board | AGAINST | 1 | |
| Nabors Industries Ltd. | June 2, 2026 | Approval, on a non-binding, advisory basis, of the compensation paid by the Company to its named executive officers. | Say-on-Pay | Board | AGAINST | 1 | |
| Nano Dimension Ltd. | December 4, 2025 | Approve Compensation Terms and Appointment of David Stehlin, CEO | Compensation | Board | AGAINST | 1 | |
| Nano Dimension Ltd. | December 4, 2025 | Approve Compensation of Company's Board of Directors | Compensation | Board | AGAINST | 1 | |
| Nano Dimension Ltd. | December 4, 2025 | Approve Extension of the Company's Employee Stock Option Plan (2015) | Compensation | Board | AGAINST | 1 | |
| Nano Dimension Ltd. | December 4, 2025 | Approve Grant of RSU to Certain Members of the Company's Board of Directors | Compensation | Board | AGAINST | 1 | |
| Nano Dimension Ltd. | December 4, 2025 | Approve Grant of RSU to Certain Members of the Company's Board of Directors for Their Service on the Company's Independent Claims Committee | Compensation | Board | AGAINST | 1 | |
| Nano Dimension Ltd. | December 4, 2025 | Approve and Ratify Compensation Terms and Appointment of Ofir Baharav, Former CEO | Compensation | Board | AGAINST | 1 | |
| Natural Grocers by Vitamin Cottage, Inc. | March 4, 2026 | Election of Directors: Zephyr Isely | Director Elections | Board | WITHHOLD | 1 | |
| Nature's Sunshine Products, Inc. | May 6, 2026 | To approve the adoption of the Nature's Sunshine Products, Inc. 2026 Stock Incentive Plan. | Compensation | Board | AGAINST | 1 | |
| Navigator Holdings Ltd. | June 15, 2026 | Elect Director Peter Stokes | Director Elections | Board | WITHHOLD | 1 | |
| Neumora Therapeutics, Inc. | May 27, 2026 | To elect three Class III directors to hold office until the 2029 annual meeting of stockholders or until their successors are elected: Paul Berns | Director Elections | Board | WITHHOLD | 1 | |
| Nexa Resources SA | June 25, 2026 | Authorize Board to Increase Share Capital | Capital Structure | Board | AGAINST | 1 | |
| Nexa Resources SA | June 25, 2026 | Authorize Board to Limit or Cancel the Preferential Subscription Right from Share Issuances | Capital Structure | Board | AGAINST | 1 | |
| Nexa Resources SA | June 25, 2026 | Increase Authorized Share Capital and Amend Article 5.8 of the Articles of Association | Capital Structure | Board | AGAINST | 1 | |
| Nexa Resources SA | June 25, 2026 | Reelect Flavio Aidar as Director | Director Elections | Board | AGAINST | 1 | |
| Nexa Resources SA | June 25, 2026 | Reelect Jaime Ardila as Director | Director Elections | Board | AGAINST | 1 | |
| Nexa Resources SA | June 25, 2026 | Reelect Luis Ermirio De Moraes as Director | Director Elections | Board | AGAINST | 1 | |
| NextDecade Corporation | June 3, 2026 | To approve and amendment to the Company's 2017 Omnibus Incentive Plan, as amended, to increase the maximum number of shares available under such plan; | Compensation | Board | AGAINST | 1 | |
| Nextdoor Holdings, Inc. | June 9, 2026 | Election of Class II Director: David Sze | Director Elections | Board | WITHHOLD | 1 | |
| Nkarta, Inc. | June 10, 2026 | Election of two directors to serve until the company's 2029 annual meeting of stockholders and until their respective successors are duly elected and qualified: Ali Behbahani, M.D., M.B.A. | Director Elections | Board | WITHHOLD | 1 | |
| Nomad Foods Limited | July 10, 2025 | Elect Director Ian G.H. Ashken | Director Elections | Board | AGAINST | 1 | |
| Nomad Foods Limited | June 22, 2026 | Elect Director James E. Lillie | Director Elections | Board | AGAINST | 1 | |
| Nomad Foods Limited | June 22, 2026 | Elect Director Melanie Stack | Director Elections | Board | AGAINST | 1 | |
| Nordic American Tankers Limited | November 21, 2025 | Elect Director Alexander Hansson | Director Elections | Board | AGAINST | 1 | |
| Nordic American Tankers Limited | November 21, 2025 | Elect Director Herbjorn Hansson | Director Elections | Board | AGAINST | 1 | |
| Nordic American Tankers Limited | November 21, 2025 | Elect Director Jenny Chu | Director Elections | Board | AGAINST | 1 | |
| Nordic American Tankers Limited | November 21, 2025 | Elect Director Jim Kelly | Director Elections | Board | AGAINST | 1 | |
| Northern Dynasty Minerals Ltd. | June 24, 2026 | Elect Director Desmond M. Balakrishnan | Director Elections | Board | WITHHOLD | 1 | |
| Northern Dynasty Minerals Ltd. | June 24, 2026 | Re-approve Share Option Plan | Compensation | Board | AGAINST | 1 | |
| Northpointe Bancshares, Inc. | May 13, 2026 | Election of Directors: Carrie L. Boer | Director Elections | Board | WITHHOLD | 1 | |
| Northpointe Bancshares, Inc. | May 13, 2026 | Election of Directors: David S. Hooker | Director Elections | Board | WITHHOLD | 1 | |
| Northpointe Bancshares, Inc. | May 13, 2026 | Election of Directors: Robert W. DeVlieger II | Director Elections | Board | WITHHOLD | 1 | |
| NovaBay Pharmaceuticals, Inc. | October 16, 2025 | To amend the 2017 Omnibus Plan to increase the authorized shares thereunder by 1,000,000 shares of Common Stock resulting in a maximum number of shares currently available for issuance of 1,021,332 shares of Common Stock and to make corresponding changes to the share grant limitations in the 2017 Omnibus Plan. | Compensation | Board | AGAINST | 1 | |
| NovaBay Pharmaceuticals, Inc. | March 12, 2026 | To approve the adoption of the 2026 Equity Incentive Plan. | Compensation | Board | AGAINST | 1 | |
| NovaBay Pharmaceuticals, Inc. | March 12, 2026 | To approve the issuance of 837,696,130 shares of common stock upon the exercise of the pre-funded warrants issued in our private placement transaction on January 16, 2026. | Capital Structure | Board | AGAINST | 1 | |
| Nu Holdings Ltd. | September 8, 2025 | Elect David Velez Osorno, Anita Mary Sands, David Alexandre Marcus, Douglas Mauro Leone, Jacqueline Dawn Reses, Luis Alberto Moreno Mejia, Roberto de Oliveira Campos Neto, Rogerio Paulo Calderon Peres and Thuan Quang Pham as Directors | Director Elections | Board | AGAINST | 1 | |
| Nu Skin Enterprises, Inc. | May 28, 2026 | Approval of our Amended and Restated 2024 Omnibus Incentive Plan | Compensation | Board | AGAINST | 1 |
← Previous Page 8 of 14 Next →
← Back to Blackstone Alternative Investment Funds 2025-2026 overview
Built November 1, 2026 from SEC Form N-PX filings.